BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11391127)

  • 21. Symptoms and signs of severe citalopram overdose.
    Grundemar L; Wohlfart B; Lagerstedt C; Bengtsson F; Eklundh G
    Lancet; 1997 May; 349(9065):1602. PubMed ID: 9174567
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparative study of QT prolongation with serotonin reuptake inhibitors.
    Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL
    Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A critical evaluation of the cardiac toxicity of citalopram: part 1.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 Nov; 49(11):13-6. PubMed ID: 22007855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of toxicity of acute overdoses with citalopram and escitalopram.
    Hayes BD; Klein-Schwartz W; Clark RF; Muller AA; Miloradovich JE
    J Emerg Med; 2010 Jul; 39(1):44-8. PubMed ID: 19081700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.
    Maljuric NM; Noordam R; Aarts N; Niemeijer MN; van den Berg ME; Hofman A; Kors JA; Stricker BH; Visser LE
    Br J Clin Pharmacol; 2015 Oct; 80(4):698-705. PubMed ID: 25966843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Citalopram overdose and severe serotonin syndrome in an intermediate metabolizing patient.
    Schult RF; Morris AJ; Picard L; Wiegand TJ
    Am J Emerg Med; 2019 Oct; 37(10):1993.e5-1993.e6. PubMed ID: 31257122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged QTc interval and torsades de pointes induced by citalopram.
    Deshmukh A; Ulveling K; Alla V; Abuissa H; Airey K
    Tex Heart Inst J; 2012; 39(1):68-70. PubMed ID: 22412232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QTc intervals in drug poisoning patients with tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Açikalin A; Satar S; Avci A; Topal M; Kuvandk G; Sebe A
    Am J Ther; 2010; 17(1):30-3. PubMed ID: 19417591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary serotonin level is associated with serotonin syndrome after moclobemide, sertraline, and citalopram overdose.
    Brvar M; Stajer D; Kozelj G; Osredkar J; Mozina M; Bunc M
    Clin Toxicol (Phila); 2007; 45(5):458-60. PubMed ID: 17503244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Escitalopram causes fewer seizures in human overdose than citalopram.
    Yilmaz Z; Ceschi A; Rauber-Lüthy C; Sauer O; Stedtler U; Prasa D; Seidel C; Hackl E; Hoffmann-Walbeck P; Gerber-Zupan G; Bauer K; Kupferschmidt H; Kullak-Ublick GA; Wilks M
    Clin Toxicol (Phila); 2010 Mar; 48(3):207-12. PubMed ID: 20170390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug monitoring of a case of citalopram overdosage.
    Liotier J; Coudoré F
    Drug Chem Toxicol; 2011 Oct; 34(4):420-3. PubMed ID: 21846175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?
    Vieweg WV; Hasnain M; Howland RH; Hettema JM; Kogut C; Wood MA; Pandurangi AK
    Am J Med; 2012 Sep; 125(9):859-68. PubMed ID: 22748401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suicide attempt by pure citalopram overdose causing long-lasting severe sinus bradycardia, hypotension and syncopes: successful therapy with a temporary pacemaker.
    Rothenhäusler HB; Hoberl C; Ehrentrout S; Kapfhammer HP; Weber MM
    Pharmacopsychiatry; 2000 Jul; 33(4):150-2. PubMed ID: 10958266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative toxicity of citalopram and the newer antidepressants after overdose.
    Kelly CA; Dhaun N; Laing WJ; Strachan FE; Good AM; Bateman DN
    J Toxicol Clin Toxicol; 2004; 42(1):67-71. PubMed ID: 15083939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors.
    Hussaarts KGAM; Berger FA; Binkhorst L; Oomen-de Hoop E; van Leeuwen RWF; van Alphen RJ; Mathijssen-van Stein D; de Groot NMS; Mathijssen RHJ; van Gelder T
    Pharm Res; 2019 Dec; 37(1):7. PubMed ID: 31845095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: a case report and literature review.
    Tseng PT; Lee Y; Lin YE; Lin PY
    Gen Hosp Psychiatry; 2012; 34(2):210.e13-5. PubMed ID: 22133983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation.
    Beach SR; Kostis WJ; Celano CM; Januzzi JL; Ruskin JN; Noseworthy PA; Huffman JC
    J Clin Psychiatry; 2014 May; 75(5):e441-9. PubMed ID: 24922496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A question about the potential cardiac toxicity of escitalopram.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Apr; 50(4):17-20. PubMed ID: 22421011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Citalopram and QT prolongation].
    Alušík Š; Paluch Z
    Vnitr Lek; 2018; 63(12):952-956. PubMed ID: 29334745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QT interval prolongation in users of selective serotonin reuptake inhibitors in an elderly surgical population: a cross-sectional study.
    van Haelst IM; van Klei WA; Doodeman HJ; Warnier MJ; De Bruin ML; Kalkman CJ; Egberts TC
    J Clin Psychiatry; 2014 Jan; 75(1):15-21. PubMed ID: 24345304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.